Comparative evaluation of biomechanical changes and aberration profile following accelerated collagen cross-linking using hypo-osmolar and iso-osmolar riboflavin: A prospective study

Indian J Ophthalmol. 2024 May 1;72(5):712-717. doi: 10.4103/IJO.IJO_1387_23. Epub 2024 Apr 22.

Abstract

Purpose: To compare the changes encountered in corneal biomechanics and aberration profile following accelerated corneal collagen cross-linking (CXL) using hypo-osmolar and iso-osmolar riboflavin in corneal thicknesses of <400 and >400 microns, respectively.

Methods: This is a prospective, interventional, comparative study involving 100 eyes of 75 patients with progressive keratoconus. Eyes were divided into two groups based on corneal thickness: group 1 included eyes with a corneal thickness of <400 microns who underwent hypo-osmolar CXL, and group 2 included eyes with a corneal thickness of >400 microns who underwent iso-osmolar CXL. Corneal biomechanical and aberration profiles were evaluated and compared between groups.

Results: In group 1, all higher-order aberrations (HOA) except secondary astigmatism significantly decreased from baseline; however, in group 2, only coma and trefoil decreased. The corneal resistance factor and corneal hysteresis significantly improved in both groups, which was significantly greater in group 2 than in group 1. The change in inverse radius, deformation amplitude, and tomographic biomechanical index was significantly improved in group 2 as compared to group 1.

Conclusion: Improvement in corrected distance visual acuity and decrease in HOA were significantly better in the hypo-osmolar CXL group; however, the improvement in biomechanical strength of the cornea was significantly better in the iso-osmolar group.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Biomechanical Phenomena
  • Child
  • Collagen* / metabolism
  • Cornea* / diagnostic imaging
  • Cornea* / drug effects
  • Cornea* / physiopathology
  • Corneal Stroma / drug effects
  • Corneal Stroma / metabolism
  • Corneal Topography*
  • Corneal Wavefront Aberration / physiopathology
  • Cross-Linking Reagents* / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Keratoconus* / diagnosis
  • Keratoconus* / drug therapy
  • Keratoconus* / physiopathology
  • Male
  • Photochemotherapy / methods
  • Photosensitizing Agents* / therapeutic use
  • Prospective Studies
  • Refraction, Ocular / physiology
  • Riboflavin* / therapeutic use
  • Ultraviolet Rays*
  • Visual Acuity* / physiology
  • Young Adult

Substances

  • Collagen
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Riboflavin